Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 294 participants.
Also called NCT04161170
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 294 participants
- Sponsor
- Registry
-
NCT04161170
-
- Other papers using this trial's data
- An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT04161170. Randomized; no masking; primary purpose treatment. Start 2019-11-20 (actual); primary completion 2021-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Digital Integrated Healthcare Platform in Patients With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Device)
- Digital integrated healthcare platform
- Lead sponsor
- Samsung Medical Center
Record details
- Record id
cardio:ct-nct04161170- Content hash
73c0a8c7917294f744a78f37b0d9802c9f5432658d79ffd30d8335fad5c6b7ec